Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery

Thrombosis and Haemostasis

Volumn 114, Issue 2, 2015, Pages 423-431

  Capodanno, Davide ^a   Musumeci, Giuseppe ^b   Lettieri, Corrado ^c   Limbruno, Ugo ^d   Senni, Michele ^b   Guagliumi, Giulio ^b   Valsecchi, Orazio ^b   Angiolillo, Dominick J ^e   Rossini, Roberta ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b Azienda Ospedaliera Papa Giovanni XXIII   (Italy)

^c CARLO POMA HOSPITAL   (Italy)

^d MISERICORDIA HOSPITAL   (Italy)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Heparin; Noncardiac surgery; Stent thrombosis

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

AGED; ARTICLE; BLEEDING; CEREBROVASCULAR DISEASE; CORONARY STENT; FEMALE; HEART DEATH; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPENSITY SCORE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SURGICAL TECHNIQUE; ACUTE CORONARY SYNDROME; ADVERSE EFFECTS; CHEMICALLY INDUCED; COMORBIDITY; COMPLICATION; CORONARY DISEASE; CORONARY RESTENOSIS; DRUG SUBSTITUTION; ELECTIVE SURGERY; HEART DISEASES; HEMORRHAGE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; STENT; STROKE; THROMBOPHILIA; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; ASPIRIN; COMORBIDITY; CORONARY DISEASE; CORONARY RESTENOSIS; DRUG SUBSTITUTION; ELECTIVE SURGICAL PROCEDURES; FEMALE; HEART DISEASES; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; STROKE; THROMBOPHILIA; TREATMENT OUTCOME;

EID: 84938263485     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-12-1057     Document Type: Article

References (22)

1. Capodanno D, Angiolillo DJ. Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and non-cardiac surgery. Circulation 2013; 128: 2785-2798.
2. Berger PB, Kleiman NS, Pencina MJ, et al. Frequency of major non-cardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Is-chaemic Events) Registry. JACC Cardiovasc Interv 2010; 3: 920-927.
3. Wijeysundera DN, Wijeysundera HC, Yun L, et al. Risk of elective major non-cardiac surgery after coronary stent insertion: a population-based study. Circulation 2012; 126: 1355-1362.
4. Rossini R, Musumeci G, Capodanno D, et al. Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry. Thromb Haemost 2015; 113: 272-282.
5. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011; 123: 2736-2747.
6. Ndrepepa G, Schuster T, Hadamitzky M, et al. Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention. Circulation 2012; 125: 1424-1431.
7. Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elev-ation myocardial infarction (updating the 2007 Guideline and replacing the 2011 Focused Update): a report of the American College of Cardiology Foun­dation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2012; 60: 645e681.
8. Cutlip DE, Windecker S, Mehran R, et al. Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115: 2344-2351.
9. Kopp VJ. Use of the American Society of Anesthesiologists Physical Status Classification System in research. Anesth Analg 2013; 117: 752.
10. Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Non-cardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 64: 77-137.
11. Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesi-ology (ESA). Eur Heart J 2014; 35: 2383-2431.
12. Hawn MT, Graham LA, Richman JS, et al. Risk of major adverse cardiac events following non-cardiac surgery in patients with coronary stents. J Am Med Assoc 2013; 310: 1462-1472.
13. Wijeysundera DN, Wijeysundera HC, Yun L, et al. Risk of elective major non-cardiac surgery after coronary stent insertion: a population-based study. Circu­lation 2012; 126: 1355-1362.
14. Mehran R, Baber U, Steg PG, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 2013; 382: 1714-1722.
15. Rossini R, Musumeci G, Visconti LO, et al. Perioperative management of anti-platelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. EuroIntervention 2014; 10: 38-46.
16. Broad L, Lee T, Conroy M, et al. Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery. Br J Anaesth 2007; 98: 19-22.
17. Vicenzi MN, Meislitzer T, Heitzinger B, et al. Coronary artery stenting and non-cardiac surgery-a prospective outcome study. Br J Anaesth 2006; 96: 686-693.
18. Mauri L, Kereiakes DJ, Yeh RW, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2014; 371: 2155-2166.
19. Mehran R, Pocock SJ, Stone GW, et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. Eur Heart J 2009; 30: 1457-1466.
20. Musumeci G, Rossini R, Lettieri C, et al. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation. Catheter Cardiovasc Interv 2012; 80: 395-405.
21. Rao SV, Ohman EM. Anticoagulant therapy for percutaneous coronary intervention. Circ Cardiovasc Interv 2010; 3: 80-88.
22. Angiolillo DJ, Firstenberg MS, Price MJ, et al. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. J Am Med Assoc 2012; 307: 265-274.